Filing metadata

Accession number
0001193125-25-192797
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Aug 29, 2025
Reporting period
Aug 27, 2025
Description
Insider transaction

Explore SEC Filings Hub